| Trial ID: | L6797 |
| Source ID: | NCT00542633
|
| Associated Drug: |
Viaject™
|
| Title: |
An Open Label, Multi-Center, Randomized, Parallel Group Study Comparing the Efficacy and Safety of Insulin VIAject™ and Regular Human Insulin in Patients With Type 2 Diabetes Mellitus
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes Mellitus
|
| Interventions: |
DRUG: VIAject™|DRUG: Regular Human Insulin
|
| Outcome Measures: |
Primary: change in HbA1c, 6 months |
|
| Sponsor/Collaborators: |
Sponsor: Biodel
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE3
|
| Enrollment: |
472
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2006-12
|
| Completion Date: |
|
| Results First Posted: |
|
| Last Update Posted: |
2015-08-18
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT00542633
|
